Please assess the completion status of the following clinical trial:

Trial Title: Opioid-induced Hyperalgesia After Remifentanil Infusion

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male~* Age 18-60~* Body mass index 17-30~* Healthy volunteers~Exclusion Criteria:~* Use of medication; alternative medicine~* Substance abuse~* Allergies towards medication used in the study~* Participation in other clinical studies the previous 6 months

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- Remifentanil (Type: EXPERIMENTAL): The study has only one arm. Same group of volunteers will receive remifentanil infusion with abrupt withdrawal, remifentanil infusion with gradual dose reduction and saline infusion at three separate trials.

Based on this trial design, predict the completion outcome and termination type (if applicable).